Fusion proteins and their use in the diagnosis and treatment of leishmaniasis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9279005
APP PUB NO 20150017200A1
SERIAL NO

14286647

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates generally to a fusion protein made from a synthetic gene construct comprising of elements derived from the Leishmania antigens K26, K39, and K9. The fusion protein is particularly useful in the diagnosis of leishmaniasis, particularly visceral leishmaniasis in animals such as humans and dogs.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ACCESS TO ADVANCED HEALTH INSTITUTE1616 EASTLAKE AVE E STE 400 SEATTLE WA 98102

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bhatia, Ajay Seattle, US 73 457
Reed, Steven G Seattle, US 156 1876

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00